# Natural History Study of MNGIE

> **NCT04245917** · — · SUSPENDED · sponsor: **Entrada Therapeutics, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Mitochondrial Neurogastrointestinal Encephalomyopathy

## Interventions

- **OTHER:** Non-interventional

## Key facts

- **NCT ID:** NCT04245917
- **Lead sponsor:** Entrada Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-08-06
- **Primary completion:** 2025-02
- **Final completion:** 2026-02
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** Business Reason
- **Last updated:** 2021-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04245917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04245917, "Natural History Study of MNGIE". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04245917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*